170 related articles for article (PubMed ID: 25337230)
1. Diagnostic value of survivin for malignant pleural effusion: a clinical study and meta-analysis.
Tian P; Shen Y; Wan C; Yang T; An J; Yi Q; Chen L; Wang T; Wang Y; Wen F
Int J Clin Exp Pathol; 2014; 7(9):5880-7. PubMed ID: 25337230
[TBL] [Abstract][Full Text] [Related]
2. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
Zhu J; Feng M; Liang L; Zeng N; Wan C; Yang T; Shen Y; Wen F
BMC Cancer; 2017 Aug; 17(1):590. PubMed ID: 28854885
[TBL] [Abstract][Full Text] [Related]
3. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
4. The diagnostic value of survivin in malignant pleural effusion: a meta-analysis.
Chen S; Wang Y; An L; Fei ZT; Li T
Clin Chim Acta; 2015 Feb; 441():142-7. PubMed ID: 25559946
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis.
Zhang Y; Li X; Liu J; Hu X; Wan C; Zhang R; Shen Y
Ann Med; 2021 Dec; 53(1):558-566. PubMed ID: 33818231
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F
Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
[TBL] [Abstract][Full Text] [Related]
9. Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions.
Park DS; Hwang KE; Shim H; Kim BR; Choi KH; Park SH; Park SD; Jeong ET; Kim HR
Clin Exp Metastasis; 2012 Feb; 29(2):83-9. PubMed ID: 22045227
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
[TBL] [Abstract][Full Text] [Related]
11. Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.
Chantharakhit C; Sujaritvanichpong N
Asian Pac J Cancer Prev; 2022 Jan; 23(1):25-31. PubMed ID: 35092368
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of periostin in lung cancer-related malignant pleural effusion.
Zhang J; Zha T; Zhang N; Sun G
J Clin Lab Anal; 2022 Feb; 36(2):e24179. PubMed ID: 35152510
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion.
Li J; Li ZN; Bao QL; Ge LP; Li XQ; Chen P
Tumour Biol; 2012 Oct; 33(5):1803-10. PubMed ID: 22696161
[TBL] [Abstract][Full Text] [Related]
14. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
Choi H; Ko Y; Lee CY
BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
[TBL] [Abstract][Full Text] [Related]
15. Clinical diagnostic utility of CA 15-3 for the diagnosis of malignant pleural effusion: A meta-analysis.
Wu Q; Li M; Zhang S; Chen L; Gu X; Xu F
Exp Ther Med; 2015 Jan; 9(1):232-238. PubMed ID: 25452808
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis.
Shi HZ; Liang QL; Jiang J; Qin XJ; Yang HB
Respirology; 2008 Jun; 13(4):518-27. PubMed ID: 18422869
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
18. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions.
Lee J; Lee YH; Seo H; Lee H; Kim YK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Am J Med Sci; 2019 Aug; 358(2):115-120. PubMed ID: 31331448
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity assay for the diagnosis of malignant pleural effusion: A meta-analysis.
Shen YC; Chen ZN; Yang T; Chen L; Wang T; Wen FQ; Yi Q
Exp Ther Med; 2012 Sep; 4(3):487-492. PubMed ID: 23181123
[TBL] [Abstract][Full Text] [Related]
20. Combining clinical and analytical parameters improves prediction of malignant pleural effusion.
Valdés L; San-José E; Ferreiro L; González-Barcala FJ; Golpe A; Álvarez-Dobaño JM; Toubes ME; Rodríguez-Núñez N; Rábade C; Lama A; Gude F
Lung; 2013 Dec; 191(6):633-43. PubMed ID: 24085319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]